ClinicalTrials.gg
RecruitingNCT04100850AEforMHUpdated May 10, 2023

Effectiveness of Aquatic Exercises for Improving Mental and Physical Health in Adults.

An interventional study of Aquatic Exercises and Watsu in Depression, Depressive Symptoms and Anxiety, sponsored by Universidade Federal do vale do São Francisco. Recruiting at 1 site in Brazil. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by Universidade Federal do vale do São Francisco · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Aug 2019; still recruiting 7 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 100 studies in Depression with a site in Brazil — 19 open to participants now, 24 under way, 3 of them phase 3. Depression · Brazil.

Planned enrollment
51st of 91
78 · median 80
Started
2019
with 6 others
No phase
62 of 100
13 open now
Primary completion
2023-12
later than 3 of 23 live
Registered
54th of 100
by date

Among the 100 studies in Depression with a site in Brazil, this one is the 51st largest by planned enrollment of the 91 interventional ones that give a count, is one of 7 that started in 2019, is one of 62 with no phase, reaches primary completion later than 3 of the 23 other live ones, and was the 54th registered.

Depression

8,602 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

19 of the 100 studies in Depression with a site in Brazil are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 100 studies in Depression with a site in Brazil, or all of them as a file.
02

Study summary

Objective: To compare the effectiveness between aquatic exercises (water aerobics versus Watsu) versus control groups, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression.

Read the detailed description

Introduction: Considered as the "21st century disease", depression is a silent disease that stands out for its high prevalence and high morbidity, leading to serious consequences. With treatments made in aquatic environment, among them the Water aerobics and Watsu. Objective: To compare the effectiveness between aquatic exercises versus Watsu and versus control group, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression. Methods: This study will be a randomized clinical trial, which will last for two months with a follow-up of one month. All participants will be assessed using specific questionnaires for each outcome and an Improvement Perception Scale (MS). Seventy eight (78) patients with a medical diagnosis of depression, aged 18 to 60 years, who will be allocated to three groups (26 patients for each group) will be treated. GROUP 1: Aquatic exercises (aerobic and resistance), collective session, twice a week lasting 50 min; GROUP 2: Watsu (water shiatsu), individual session, twice a week lasting 50 min; Group 3: control, people with depression. Statistical analysis: Normality distribution will be by Shapiro-Wilk test. For comparisons of the means between and within the outcome groups will be used through Generalized Estimation Equations, with its own syntax, linear distribution and, when necessary, multiple comparisons will be performed using the Bonferroni test to identify differences. Will be calculated for comparisons between the final and initial moments and initial follow-up in each group, statistics such as: mean difference (95% CI), standard deviation of the difference, effect size (Cohen's d). The statistical significance adopted was 5% and the analyzes were performed using the statistical programs SPSS 22.0 and R 3.2.4. The intention-to-treat analysis will be performed.

03

Conditions studied

  • Depression
  • Depressive Symptoms
  • Anxiety

Keywords

  • hydrotherapy
  • depression
  • anxiety
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 60 years old;
  • Sedentary and who have not had physical therapy and physical activity in the last three months;
  • Clinical and cognitive conditions for performing pool activities and moderate aerobic exercise;
  • Who have not undergone high complexity surgical procedures in the last six months; no neuro-musculosqueletal diseases;
  • No to exercise; such as: urinary and / or fecal incontinence and dermatological diseases;
  • Individuals with a medical diagnosis of depression.

Exclusion criteria

Exclusion Criteria:

  • If they have up to three absences during the intervention period;
  • If they have any adverse effects, such as: allergy or dermatitis;
  • Unable to continue study due to change of address or hospitalization.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Aquatic Exercises

    Aquatic Exercises (AE) are water aerobics exercises and resistance exercises, classes will be supervised by a Physical Educator, in collective sessions of up to 30 people per class, twice a week, lasting 50 minutes, for two months.

    Other: Aquatic Exercises

  • Active comparator
    Watsu

    The Watsu (water shiatsu) will be applied by a physical therapist, in individual sessions, twice a week, lasting 50 minutes, for two months in a warn pool (± 34°C). Watsu in particular prescribes transition of movements, once they are instituted, the therapist can create and adapt according to the limitations and restrictions that are encountered.

    Other: Watsu

  • No intervention
    Control

    The control group will not receive any of these treatments (aquatic exercises and Watsu).

Interventions

  • OtherAquatic Exercises

    twice a week, lasting 50 minutes, for two months.

    Also known as: Aquatic Exercises (AE)

  • OtherWatsu

    twice a week, lasting 50 minutes, for two months.

    Also known as: Water Shiatsu (WS)

06

What researchers measure

Primary outcomes

  1. Depression

    Beck Depression Inventory (better 0-63 worse points)

    Time frame: change depression at 8 weeks and follow-up at 12 weeks

  2. Anxiety

    Beck Anxiety Inventory (better 0-63 worse points)

    Time frame: change anxiety at 8 weeks and follow-up at 12 weeks

Secondary outcomes

  1. Stress

    Depression, Anxiety and Stress Scale (DASS-21) (better 0 - worse \>34)

    Time frame: change stress at 8 weeks and follow-up at 12 weeks

  2. Quality of Life Questionnaire

    12-Item Short-Form Health Survey (SF-12) (worse 0 - better 100)

    Time frame: change quality of live at 8 weeks and follow-up at 12 weeks

  3. Sleep Quality

    Pittsburgh Sleep Quality Index (PSQI) (better 0 - worse 21)

    Time frame: change sleep quality at 8 weeks and follow-up at 12 weeks

  4. Life Style Scale

    Fantastic Life Style Scale (worse 0 - better 100)

    Time frame: change life style at 8 weeks and follow-up at 12 weeks

  5. Cognitive

    Montreal Cognitive Assessment (MOCA) (worse 0 - better 30)

    Time frame: change cognitive at 8 weeks and follow-up at 12 weeks

  6. Functionally

    Six-minute Walk Test (6m-WT)

    Time frame: change functionally at 8 weeks and follow-up at 12 weeks

Other outcomes

  1. Improvement Perception

    Improvement Perception Scale (0-7)

    Time frame: pos (8 week)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Study Protocol, Randomized Clinical Trial

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2019 (actual). Primary completion is estimated for Dec 2023, 52 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 52 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 20, 2019
First posted
Sep 24, 2019
StartActual
Aug 1, 2019
Primary completionEst.
Dec 31, 2023
CompletionEst.
Dec 31, 2023
Last update
May 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04100850
Lead sponsor
Universidade Federal do vale do São Francisco
Responsible party
Rodrigo Gustavo da Silva Carvalho (Principal Investigator, Universidade Federal do vale do São Francisco) — Principal investigator
First posted
Sep 24, 2019
Start date
Aug 1, 2019
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
May 10, 2023

Study contacts

Rodrigo GS Carvalho, PhD
Contact
rodrigocarvalhofisio@gmail.com
+5587999832015
Rodrigo GS Carvalho, Phd
Contact
rodrigo.carvalho@univasf.edu.br
+558721016856
Rodrigo GS Carvalho, PhD
principal investigator · Physical Education College / UNIVASF

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion